BIOMAT Database Logo BIOMAT Database Logo

Structure-Based Design, Synthesis and Bioactivity of a New Anti-TNFα Cyclopeptide. 2020

Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
Institute of Medical Sciences, University of Aberdeen, Ashgrove Road West, Aberdeen AB25 2ZD, UK.

As opposed to small molecules, macrocyclic peptides possess a large surface area and are recognised as promising candidates to selectively treat diseases by disrupting specific protein-protein interactions (PPIs). Due to the difficulty in predicting cyclopeptide conformations in solution, the de novo design of bioactive cyclopeptides remains significantly challenging. In this study, we used the combination of conformational analyses and molecular docking studies to design a new cyclopeptide inhibitor of the interaction between the human tumour necrosis factor alpha (TNFα) and its receptor TNFR-1. This interaction is a key in mediating the inflammatory response to tissue injury and infection in humans, and it is also an important causative factor of rheumatoid arthritis, psoriasis and inflammatory bowel disease. The solution state NMR structure of the cyclopeptide was determined, which helped to deduce its mode of interaction with TNFα. TNFα sensor cells were used to evaluate the biological activity of the peptide.

UI MeSH Term Description Entries
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D017433 Protein Structure, Secondary The level of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to ALPHA-HELICES; BETA-STRANDS (which align to form BETA-SHEETS), or other types of coils. This is the first folding level of protein conformation. Secondary Protein Structure,Protein Structures, Secondary,Secondary Protein Structures,Structure, Secondary Protein,Structures, Secondary Protein
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell

Related Publications

Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
[Structure-based design, synthesis and evaluation of bioactivity of anti-P-gp peptide mimetic].
November 2003, Yao xue xue bao = Acta pharmaceutica Sinica,
Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
Linked magnolol dimer as a selective PPARγ agonist - Structure-based rational design, synthesis, and bioactivity evaluation.
October 2017, Scientific reports,
Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
Synthesis and structure-activity correlation of a brunsvicamide-inspired cyclopeptide collection.
May 2009, Chembiochem : a European journal of chemical biology,
Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
In silico structure-based design and synthesis of novel anti-RSV compounds.
October 2015, Antiviral research,
Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
Structure-based design, synthesis and preliminary anti-inflammatory activity of bolinaquinone analogues.
February 2011, European journal of medicinal chemistry,
Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
Structure-based design, synthesis, and antifungal activity of new triazole derivatives.
August 2011, Chemical biology & drug design,
Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
Design, Synthesis, and Bioactivity Evaluation of New Thiochromanone Derivatives Containing a Carboxamide Moiety.
July 2021, Molecules (Basel, Switzerland),
Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
Cyclopeptide-based Anti-liver Cancer Agents: A Mini-review.
January 2023, Protein and peptide letters,
Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents.
July 2018, MedChemComm,
Mohannad Idress, and Bruce F Milne, and Gary S Thompson, and Laurent Trembleau, and Marcel Jaspars, and Wael E Houssen
Synthesis of New Cyclopeptide Analogues of the Miuraenamides.
January 2021, Current organic synthesis,
Copied contents to your clipboard!